Fig. 15From: Predicted antiviral drugs Darunavir, Amprenavir, Rimantadine and Saquinavir can potentially bind to neutralize SARS-CoV-2 conserved proteinsActive site residues & drug binding motifs of NSP12. a Position of active site residues. b, c Different surfaces showing 478, 017, RIM and ROC binding interfaces or residues. 478-Amprenavir; 017-Darunavir; RIM Rimantadine, ROC SaquinavirBack to article page